Post the second wave in India, the medical fraternity has been working hard in controlling any further surge, and treating patients with newer ways for a guaranteed recovery. The scientists worldwide are busy working on several vaccines and therapies to take care of next waves of Covid. And, one such in the recent times has been monoclonal antibody therapy.
Sir Ganga Ram Hospital in the national capital reported successful usage of this therapy for treating two COVID-19 patients this week. And, the good news is that both the COVID-19 patients managed to recover from their ailments and were discharged within 12 hours.
What is Monoclonal Anti-body Therapy?
According to a report on BBC, monoclonal antibodies are particularly promising in therapy because they can neutralize the SARS-CoV-2 virus, which causes COVID-19, and block its ability to infect a cell. This might be a lifesaving intervention in people who are unable to mount a strong natural immune response to the virus – those over 65 or with existing conditions that make them more vulnerable.
In a press release, the hospital stated, “Monoclonal antibody could prove to be a game-changer in times to come if used at an appropriate time. It can avoid hospitalization in high-risk groups and progression to severe disease. It can help escaping or reducing the usage of steroids and immuno-modulation which would further reduce the risk of fatal infections like mucormycosis, secondary bacterial and viral infections like CMV,” said Dr Pooja Khosla, a senior consultant of the Department of Medicine at Sir Ganga Ram Hospital.